Privilège Ventures: Pre-Seed to Seed

Investment focus

Sectors

Investment stages

Geographic focus

Inferred thesis

Auto-generated from public data. Not the firm's stated position.

Privilège Ventures appears to focus on early-stage European deep tech and health-tech companies, with recent portfolio activity suggesting an emphasis on wearable diagnostics and specialized software solutions across the pre-seed to seed stages. The disclosed check size of €1.5M–€3.0M indicates positioning as a lead or co-lead investor in this early funding window.

Generated 16 Oct 2026 from disclosed sectors, stages, and portfolio companies. Is this your firm? Claim the profile to correct it.

How to Pitch Privilège Ventures

No stated policy
Privilège Ventures hasn't published an outreach policy. A short, specific cold email is the safest default.
Source

Portfolio highlights

Smeetz - ticketing SaaS
Xsensio - wearable biosensors
Avelo - breath diagnostics

Focus and check size from the firm's website. Website reachable as of Nov 2026.

Ready to reach Privilège Ventures?

Red-pen your deck first so the gaps are fixed before they read it. A fit check then scores your pitch against their thesis, stage and ticket, and an email draft uses their real deals and thesis, not a template.

Contact

privilege-ventures.com

Reach Privilège Ventures through the links above. Pitchkit is not affiliated with the firm and does not forward pitches.